News

Inbiomotion creates a world class Scientific Advisory Board chaired by Prof. Rob E. Coleman

Inbiomotion SL, a company focused on the development of biomarkers for the prediction of bone metastasis, today announced the creation of its Scientific Advisory Board with renowned experts in various disciplines, including bone metastatic disease, biomarker development, translational research and medical oncology.